Evaluate and optimize your downstream processing performance with our characterization CDMO solutions.
Downstream process characterization evaluates downstream purification processes using analytical methods to ensure consistent yield and purity of biologics.
With our downstream process characterization services, we can help you to:
We can support your process characterization with studies including:
We are a global CDMO and biosimilar developer dedicated to impacting the global healthcare landscape by bringing trusted and affordable medicines to market, quickly.
Committed to innovation, we have revolutionized biologics production with our patented and validated continuous bioprocess manufacturing platform, EnzeneX™, that enables us to significantly reduce the cost of producing complex biologics and monoclonal antibodies (mAbs).
Our fully-integrated services and productive pipeline of biosimilars, along with our downstream process characterization solutions, are designed to cater to your project’s every need.
Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.